Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wenzel

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Stress, immunity, and cervical cancer: biobehavioral outcomes of a randomized clinical trial [corrected]Edward L Nelson, Lari B Wenzel, Kathryn Osann, et al.
Gynecologic Oncology|October 24, 2007
Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public WorkshopRobert C Bast, J Tate Thigpen, Susan G Arbuck, et al.
ESMO Real World Data and Digital Oncology|April 3, 2026
Ovarian cancer recurrence prediction: comparing confirmatory to real-world predictors with machine learningD Katsimpokis, A E C van Odenhoven, M A J M van Erp, et al.
Cancers|February 10, 2024
Survival of Women with Advanced Stage Cervical Cancer: Neo-Adjuvant Chemotherapy Followed by Radiotherapy and Hyperthermia versus ChemoradiotherapyJonathan Servayge, Ester P Olthof, Constantijne H Mom, et al.
Cancer Treatment Reviews|November 13, 2021
Primary or adjuvant chemoradiotherapy for cervical cancer with intraoperative lymph node metastasis - A reviewHans H B Wenzel, Ester P Olthof, Ruud L M Bekkers, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 13, 2007
Health-related quality of life in a racially diverse population screened for hemochromatosis: results from the Hemochromatosis and Iron Overload Screening (HEIRS) studyLari B Wenzel, Roger Anderson, Diane C Tucker, et al.
The Lancet. Oncology|February 2, 2015
Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240)Richard T Penson, Helen Q Huang, Lari B Wenzel, et al.
European Journal of Cancer (Oxford, England : 1990)|May 19, 2020
Survival of patients with early-stage cervical cancer after abdominal or laparoscopic radical hysterectomy: a nationwide cohort study and literature reviewHans H B Wenzel, Ramon G V Smolders, Jogchum J Beltman, et al.
Gynecologic Oncology|December 14, 2021
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology studyUrsula A Matulonis, Helen Q Huang, Virginia L Filiaci, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 2, 2020
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group studyDana Chase, Helen Q Huang, Bradley J Monk, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Stress, immunity, and cervical cancer: biobehavioral outcomes of a randomized clinical trial [corrected]Edward L Nelson, Lari B Wenzel, Kathryn Osann, et al.
Gynecologic Oncology|October 24, 2007
Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public WorkshopRobert C Bast, J Tate Thigpen, Susan G Arbuck, et al.
ESMO Real World Data and Digital Oncology|April 3, 2026
Ovarian cancer recurrence prediction: comparing confirmatory to real-world predictors with machine learningD Katsimpokis, A E C van Odenhoven, M A J M van Erp, et al.
Cancers|February 10, 2024
Survival of Women with Advanced Stage Cervical Cancer: Neo-Adjuvant Chemotherapy Followed by Radiotherapy and Hyperthermia versus ChemoradiotherapyJonathan Servayge, Ester P Olthof, Constantijne H Mom, et al.
Cancer Treatment Reviews|November 13, 2021
Primary or adjuvant chemoradiotherapy for cervical cancer with intraoperative lymph node metastasis - A reviewHans H B Wenzel, Ester P Olthof, Ruud L M Bekkers, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 13, 2007
Health-related quality of life in a racially diverse population screened for hemochromatosis: results from the Hemochromatosis and Iron Overload Screening (HEIRS) studyLari B Wenzel, Roger Anderson, Diane C Tucker, et al.
The Lancet. Oncology|February 2, 2015
Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240)Richard T Penson, Helen Q Huang, Lari B Wenzel, et al.
European Journal of Cancer (Oxford, England : 1990)|May 19, 2020
Survival of patients with early-stage cervical cancer after abdominal or laparoscopic radical hysterectomy: a nationwide cohort study and literature reviewHans H B Wenzel, Ramon G V Smolders, Jogchum J Beltman, et al.
Gynecologic Oncology|December 14, 2021
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology studyUrsula A Matulonis, Helen Q Huang, Virginia L Filiaci, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 2, 2020
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group studyDana Chase, Helen Q Huang, Bradley J Monk, et al.
Pageof 10